title: The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
authors.affiliation: Cardiovascular Pharmacology Division, ISF College of Pharmacy, Moga 142 001, Punjab, India.
authors.forename: Mandeep Kumar
authors.initials: MK
authors.lastname: Arora
authors.forename: Krishna
authors.initials: K
authors.lastname: Reddy
authors.forename: Pitchai
authors.initials: P
authors.lastname: Balakumar